Cargando…

Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?

OBJECTIVE: Chronic exercise and obesity both increase intramyocellular triglycerides (IMTGs) despite having opposing effects on insulin sensitivity. We hypothesized that chronically exercise-trained muscle would be characterized by lower skeletal muscle diacylglycerols (DAGs) and ceramides despite h...

Descripción completa

Detalles Bibliográficos
Autores principales: Amati, Francesca, Dubé, John J., Alvarez-Carnero, Elvis, Edreira, Martin M., Chomentowski, Peter, Coen, Paul M., Switzer, Galen E., Bickel, Perry E., Stefanovic-Racic, Maja, Toledo, Frederico G.S., Goodpaster, Bret H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178290/
https://www.ncbi.nlm.nih.gov/pubmed/21873552
http://dx.doi.org/10.2337/db10-1221
_version_ 1782212379997634560
author Amati, Francesca
Dubé, John J.
Alvarez-Carnero, Elvis
Edreira, Martin M.
Chomentowski, Peter
Coen, Paul M.
Switzer, Galen E.
Bickel, Perry E.
Stefanovic-Racic, Maja
Toledo, Frederico G.S.
Goodpaster, Bret H.
author_facet Amati, Francesca
Dubé, John J.
Alvarez-Carnero, Elvis
Edreira, Martin M.
Chomentowski, Peter
Coen, Paul M.
Switzer, Galen E.
Bickel, Perry E.
Stefanovic-Racic, Maja
Toledo, Frederico G.S.
Goodpaster, Bret H.
author_sort Amati, Francesca
collection PubMed
description OBJECTIVE: Chronic exercise and obesity both increase intramyocellular triglycerides (IMTGs) despite having opposing effects on insulin sensitivity. We hypothesized that chronically exercise-trained muscle would be characterized by lower skeletal muscle diacylglycerols (DAGs) and ceramides despite higher IMTGs and would account for its higher insulin sensitivity. We also hypothesized that the expression of key skeletal muscle proteins involved in lipid droplet hydrolysis, DAG formation, and fatty-acid partitioning and oxidation would be associated with the lipotoxic phenotype. RESEARCH DESIGN AND METHODS: A total of 14 normal-weight, endurance-trained athletes (NWA group) and 7 normal-weight sedentary (NWS group) and 21 obese sedentary (OBS group) volunteers were studied. Insulin sensitivity was assessed by glucose clamps. IMTGs, DAGs, ceramides, and protein expression were measured in muscle biopsies. RESULTS: DAG content in the NWA group was approximately twofold higher than in the OBS group and ~50% higher than in the NWS group, corresponding to higher insulin sensitivity. While certain DAG moieties clearly were associated with better insulin sensitivity, other species were not. Ceramide content was higher in insulin-resistant obese muscle. The expression of OXPAT/perilipin-5, adipose triglyceride lipase, and stearoyl-CoA desaturase protein was higher in the NWA group, corresponding to a higher mitochondrial content, proportion of type 1 myocytes, IMTGs, DAGs, and insulin sensitivity. CONCLUSIONS: Total myocellular DAGs were markedly higher in highly trained athletes, corresponding with higher insulin sensitivity, and suggest a more complex role for DAGs in insulin action. Our data also provide additional evidence in humans linking ceramides to insulin resistance. Finally, this study provides novel evidence supporting a role for specific skeletal muscle proteins involved in intramyocellular lipids, mitochondrial oxidative capacity, and insulin resistance.
format Online
Article
Text
id pubmed-3178290
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31782902012-10-01 Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes? Amati, Francesca Dubé, John J. Alvarez-Carnero, Elvis Edreira, Martin M. Chomentowski, Peter Coen, Paul M. Switzer, Galen E. Bickel, Perry E. Stefanovic-Racic, Maja Toledo, Frederico G.S. Goodpaster, Bret H. Diabetes Pathophysiology OBJECTIVE: Chronic exercise and obesity both increase intramyocellular triglycerides (IMTGs) despite having opposing effects on insulin sensitivity. We hypothesized that chronically exercise-trained muscle would be characterized by lower skeletal muscle diacylglycerols (DAGs) and ceramides despite higher IMTGs and would account for its higher insulin sensitivity. We also hypothesized that the expression of key skeletal muscle proteins involved in lipid droplet hydrolysis, DAG formation, and fatty-acid partitioning and oxidation would be associated with the lipotoxic phenotype. RESEARCH DESIGN AND METHODS: A total of 14 normal-weight, endurance-trained athletes (NWA group) and 7 normal-weight sedentary (NWS group) and 21 obese sedentary (OBS group) volunteers were studied. Insulin sensitivity was assessed by glucose clamps. IMTGs, DAGs, ceramides, and protein expression were measured in muscle biopsies. RESULTS: DAG content in the NWA group was approximately twofold higher than in the OBS group and ~50% higher than in the NWS group, corresponding to higher insulin sensitivity. While certain DAG moieties clearly were associated with better insulin sensitivity, other species were not. Ceramide content was higher in insulin-resistant obese muscle. The expression of OXPAT/perilipin-5, adipose triglyceride lipase, and stearoyl-CoA desaturase protein was higher in the NWA group, corresponding to a higher mitochondrial content, proportion of type 1 myocytes, IMTGs, DAGs, and insulin sensitivity. CONCLUSIONS: Total myocellular DAGs were markedly higher in highly trained athletes, corresponding with higher insulin sensitivity, and suggest a more complex role for DAGs in insulin action. Our data also provide additional evidence in humans linking ceramides to insulin resistance. Finally, this study provides novel evidence supporting a role for specific skeletal muscle proteins involved in intramyocellular lipids, mitochondrial oxidative capacity, and insulin resistance. American Diabetes Association 2011-10 2011-09-16 /pmc/articles/PMC3178290/ /pubmed/21873552 http://dx.doi.org/10.2337/db10-1221 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Pathophysiology
Amati, Francesca
Dubé, John J.
Alvarez-Carnero, Elvis
Edreira, Martin M.
Chomentowski, Peter
Coen, Paul M.
Switzer, Galen E.
Bickel, Perry E.
Stefanovic-Racic, Maja
Toledo, Frederico G.S.
Goodpaster, Bret H.
Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
title Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
title_full Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
title_fullStr Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
title_full_unstemmed Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
title_short Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?
title_sort skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?
topic Pathophysiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178290/
https://www.ncbi.nlm.nih.gov/pubmed/21873552
http://dx.doi.org/10.2337/db10-1221
work_keys_str_mv AT amatifrancesca skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT dubejohnj skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT alvarezcarneroelvis skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT edreiramartinm skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT chomentowskipeter skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT coenpaulm skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT switzergalene skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT bickelperrye skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT stefanovicracicmaja skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT toledofredericogs skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes
AT goodpasterbreth skeletalmuscletriglyceridesdiacylglycerolsandceramidesininsulinresistanceanotherparadoxinendurancetrainedathletes